Inclusion Criteria:
  -  Subject-reported history of dry eye disease in both eyes for at least 6 months;
  -  History of use of artificial tear eye drops for dry eye symptoms;
  -  Total score of â‰¥40 on SANDE;
  -  TFBUT;
  -  Corneal fluorescein staining;
  -  Lissamine green conjunctival staining;
  -  Schirmer's test score.
Exclusion Criteria:
  -  Have participated in a previous tavilermide (MIM-D3) study;
  -  Have clinically significant slit lamp findings at Visit 1;
  -  Have a history of lacrimal duct obstruction within 12 months of Visit 1;
  -  Have an uncontrolled systemic disease;
  -  Be a woman who is pregnant, nursing or planning a pregnancy;
  -  Be a woman of childbearing potential who is not using an acceptable means of birth control;
  -  Have a condition or be in a situation which the investigator feels may put the subject at significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study;
  -  Be currently enrolled in an investigational drug or device study or have used an investigational drug or device within 45 days prior to Visit 1.